Innovation in Oligonucleotide Manufacturing Symposium
April 29, 2025 - Glasgow
Ypso-Facto will be attending the Innovation in Oligonucleotide Manufacturing Symposium, organized by CPI, on April 29, 2025, at the Medicines Manufacturing Innovation Centre in Paisley, Glasgow.
This symposium will bring together key stakeholders from across the sector to highlight emerging process technologies in the field and explore how these processes can be effectively developed and optimized to enable scalable, efficient manufacturing.
Oligonucleotides represent a groundbreaking class of therapeutics in the pharmaceutical industry. These short, chemically synthesized fragments of DNA or RNA regulate protein expression through various mechanisms, addressing the root causes of disease. They hold promise for a wide range of conditions, from cancer to Alzheimer’s, and have the potential to revolutionize treatment for currently untreatable diseases while improving therapeutic options for widespread conditions such as heart disease.
We look forward to insightful discussions on the future of oligonucleotide manufacturing and the opportunity to connect with experts driving innovation in this rapidly evolving field.
Contact us to book a meeting during the event : contact@ypso-facto.com
Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.